索宝蛋白
(603231)
| 流通市值：19.80亿 | | | 总市值：35.67亿 |
| 流通股本：1.06亿 | | | 总股本：1.91亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 159,187,383.97 | 260,620,278.75 | 124,349,141.98 | 320,026,347.41 |
| 交易性金融资产 | 656,335,232.42 | 487,475,277.65 | 610,513,634.11 | 500,231,118.8 |
| 应收票据及应收账款 | 150,305,195.05 | 167,013,472.21 | 158,633,551.23 | 164,438,641.96 |
| 其中：应收票据 | 7,691,570 | 18,829,289.94 | 13,373,329.94 | 15,804,164.71 |
| 应收账款 | 142,613,625.05 | 148,184,182.27 | 145,260,221.29 | 148,634,477.25 |
| 应收款项融资 | 1,481,072.98 | 325,843.19 | 8,457,246.75 | 6,343,909.15 |
| 预付款项 | 28,992,632.07 | 31,224,780.33 | 96,812,936.06 | 13,137,272.72 |
| 其他应收款合计 | 17,400,693.83 | 4,663,755.43 | 13,803,117.09 | 7,293,726.03 |
| 存货 | 258,977,667.92 | 285,889,553.3 | 307,541,074.37 | 279,399,036.07 |
| 其他流动资产 | 20,426,775.17 | 21,919,921.82 | 8,400,416.64 | 6,055,607.51 |
| 流动资产合计 | 1,293,106,653.41 | 1,259,132,882.68 | 1,328,511,118.23 | 1,296,925,659.65 |
| 非流动资产: | | | | |
| 长期股权投资 | 11,600,505.65 | 12,472,941.69 | 12,552,886.67 | 13,706,941.35 |
| 固定资产 | 765,093,737.6 | 701,993,262.88 | 597,621,917.72 | 612,221,966.53 |
| 在建工程 | 34,234,471.39 | 52,949,854.78 | 126,648,379.57 | 92,623,009.76 |
| 使用权资产 | 1,011,961.08 | 468,266.22 | 815,721.6 | 875,722.27 |
| 无形资产 | 60,300,760.45 | 60,865,258.19 | 61,150,100.91 | 61,688,556.38 |
| 递延所得税资产 | 3,981,382.13 | 3,940,129.52 | 4,058,637.18 | 3,959,467.23 |
| 其他非流动资产 | 4,502,528.17 | 5,529,722.72 | 6,135,332.1 | 2,648,590.77 |
| 非流动资产合计 | 880,725,346.47 | 838,219,436 | 808,982,975.75 | 787,724,254.29 |
| 资产总计 | 2,173,831,999.88 | 2,097,352,318.68 | 2,137,494,093.98 | 2,084,649,913.94 |
| 流动负债: | | | | |
| 短期借款 | 23,774,000 | 23,774,000 | 23,774,000 | 23,774,000 |
| 应付票据及应付账款 | 102,276,771.36 | 84,592,808.96 | 134,919,375.67 | 120,217,223.77 |
| 应付账款 | 102,276,771.36 | 84,592,808.96 | 134,919,375.67 | 120,217,223.77 |
| 合同负债 | 12,396,051.49 | 7,554,686.7 | 6,486,110.27 | 5,571,860.32 |
| 应付职工薪酬 | 16,521,754.41 | 15,607,766.57 | 8,774,004.89 | 20,970,594.94 |
| 应交税费 | 14,167,209.47 | 11,674,029 | 15,004,104.71 | 9,072,972.7 |
| 其他应付款合计 | 11,709,059.7 | 2,289,926.32 | 2,859,563.63 | 2,792,883.33 |
| 一年内到期的非流动负债 | 706,059.9 | 38,915.09 | 494,106.13 | 714,395.98 |
| 其他流动负债 | 8,774,119.67 | 17,196,158.1 | 6,084,972.78 | 7,716,737.92 |
| 流动负债合计 | 190,325,026 | 162,728,290.74 | 198,396,238.08 | 190,830,668.96 |
| 非流动负债: | | | | |
| 递延收益 | 13,549,327.48 | 13,752,305.81 | 13,716,367.47 | 12,627,595.79 |
| 递延所得税负债 | 6,267,887.83 | 6,427,232.11 | 6,483,301.91 | 6,773,448.11 |
| 非流动负债合计 | 19,817,215.31 | 20,179,537.92 | 20,199,669.38 | 19,401,043.9 |
| 负债合计 | 210,142,241.31 | 182,907,828.66 | 218,595,907.46 | 210,231,712.86 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 191,459,105 | 191,459,105 | 191,459,105 | 191,459,105 |
| 资本公积 | 1,237,495,066.7 | 1,237,495,066.7 | 1,237,495,066.7 | 1,237,495,066.7 |
| 其他综合收益 | 13,481.52 | 23,716.31 | -4,017.03 | -7,910.06 |
| 盈余公积 | 43,366,961.84 | 43,366,961.84 | 43,366,961.84 | 43,366,961.84 |
| 未分配利润 | 491,355,143.51 | 442,099,640.17 | 446,581,070.01 | 402,104,977.6 |
| 归属于母公司股东权益合计 | 1,963,689,758.57 | 1,914,444,490.02 | 1,918,898,186.52 | 1,874,418,201.08 |
| 股东权益合计 | 1,963,689,758.57 | 1,914,444,490.02 | 1,918,898,186.52 | 1,874,418,201.08 |
| 负债和股东权益合计 | 2,173,831,999.88 | 2,097,352,318.68 | 2,137,494,093.98 | 2,084,649,913.94 |
| 公告日期 | 2025-10-31 | 2025-08-28 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |